Future pharma

When:
January 31, 2018 @ 7:00 pm – 8:30 pm
2018-01-31T19:00:00+00:00
2018-01-31T20:30:00+00:00
Where:
The Royal Institution
21 Albemarle St
Mayfair, London W1S
UK
Cost:
£16/£10
Contact:
The Royal Institution

For centuries we’ve been using chemicals to improve health, but taking pills seems so 20th century. Join five scientists on the cutting-edge of pharmaceutical research and hear about the latest in gene therapy, cancer treatment and more. Get a sneak peek at the drugs of the future.

Ijeoma Uchegbu is a professor of Pharmaceutical Nanoscience at UCL. Her research focuses on designing drugs that can cross the blood-brain barrier. She won the Royal Pharmaceutical Society’s Pharmaceutical Scientist of the Year Award in 2012

Catherine Tuleu is a professor of Paediatric Pharmaceutics at UCL. The main focus of her research concerns drug delivery systems for neonates, infants and children.

Sejal Ranmal is Director of Formulation at Intract Pharma, a science-driven licensing and product development company specialising in gastrointestinal models and state-of-the-art formulation technologies for development of advanced therapeutics.

Stephen Hart is a professor in Molecular Genetics at UCL. His research focuses on developing gene therapies for cardiovascular and respiratory disease, as well as cancer.

Wafa Al-Jamal is a reader in the School of Pharmacy at Queen’s University Belfast. Currently, her research focuses on developing smart vectors for delivering a broad range of therapeutic agents, and to fabricate multifunctional nanoparticles to target cancer and other diseases.